ABSI
NASDAQ
$8.16
Absci Corp (ABSI)
Absci Corp (ABSI) is a cutting-edge biotechnology company that utilizes a proprietary AI-driven platform to revolutionize drug discovery and development. By facilitating the rapid generation of high-quality proteins and therapeutic candidates, Absci effectively shortens development timelines and lowers associated costs, establishing itself as a key innovator within the biopharmaceutical sector. The company's robust pipeline, complemented by strategic partnerships, underscores its commitment to advancing next-generation therapies that address critical medical needs and improve patient outcomes.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $13.78 (+68.87%)
Market Cap
$1.49B
Free Cash Flow Yield
-6.61%
Beta (5Y)
2.33
Price Chart
Valuation
Market Cap$1.49B
P/S900.52
P/B10.08
Profitability
Total Revenue (TTM)$1.84M
Gross Profit (TTM)-$82M
EBITDA-$112M
Operating Margin-14347%
EPS-$0.84
Financial Health
Free Cash Flow Yield-6.61%
Growth & Risk
Revenue 5Y CAGR-18.34%
Beta (5Y)2.33
Sharpe Ratio1.46